https://www.tscan.com/privacy-policy/
Privacy Policy - TScan Therapeutics, Inc.
May 14, 2026 - Privacy Policy Effective date: June 8, 2025 At TScan Therapeutics, Inc. (“TScan”) we know you care about how your Personal Data is used and shared, and we take...
privacy policytscantherapeuticsinc
https://www.tscan.com/job/flow-core-technician/
Flow Core Technician – TScan Therapeutics
TScan is seeking a research professional with demonstrated expertise in flow cytometry and instrumentation to join our team as Flow Cytometry Technician, to...
flow coretechniciantscantherapeutics
https://www.tscan.com/our-approach/our-science/
Our Science – TScan Therapeutics
Jan 14, 2026 - TCR-T Cell Therapies T cells, or T lymphocytes, are a type of white blood cell that plays a central role in the immune system. They are named “T cells” because...
sciencetscantherapeutics
https://www.tscan.com/about/
Clinical-Stage Biotech Company | About TScan Therapeutics
May 12, 2026 - TScan Therapeutics is a clinical-stage biotechnology company building a robust pipeline of engineered TCR-T cell therapies for cancer.
clinical stagebiotech companytscantherapeutics
https://www.tscan.com/about/board-of-directors/
Board of Directors – TScan Therapeutics
boarddirectorstscantherapeutics
https://www.tscan.com/science/publications/?e-filter-0a4a7cc-category=papers
TScan Therapeutics Publications & Research
Apr 13, 2026 - Browse TScan Therapeutics' latest publications, research papers, and scientific findings on TCR-T therapies and early stage research.
tscantherapeuticspublicationsresearch
https://www.tscan.com/contact/
Contact TScan Therapeutics | Get in Touch with our team.
May 14, 2026 - Contact TScan Therapeutics. Reach out to our team for partnership inquiries, media relations, or general questions about our TCR-T programs.
tscantherapeuticsgettouchteam
https://www.tscan.com/our-approach/autoimmunity/
Autoimmunity – TScan Therapeutics
Jan 14, 2026 - While primarily focused on oncology, we believe our TargetScan technology is also well suited to identify unknown targets that cause T cell-driven autoimmune...
autoimmunitytscantherapeutics
https://www.tscan.eu/
tSCAN
Oct 30, 2025 - Scan, diagnose, engage, sell. Thanks to our innovative scan solutions your customer's tyres, alignment and bodywork can be inspected quickly and automatically.
tscan
https://www.tscan.com/pipeline/partners/
Partners - TScan Therapeutics, Inc.
May 20, 2026 - We work with key collaborators, including academic institutions, pharmaceutical companies, and other key partners to advance our programs and discover new...
partnerstscantherapeuticsinc
https://www.tscan.com/job-posting/manager-quality-systems/
Manager, Quality Systems - TScan Therapeutics, Inc.
quality systemsmanagertscantherapeuticsinc
https://www.tscan.com/about/our-company/
Our Company – TScan Therapeutics
Jan 14, 2026 - Our lead TCR-T therapy candidate, TSC-101, is in development for the treatment of patients with hematologic malignancies, including acute myeloid leukemia...
companytscantherapeutics
https://www.tscan.com/our-approach/hematologic-malignancies/
Hematologic Malignancies – TScan Therapeutics
Jan 6, 2026 - TSC-101 is an HA-2-specific TCR-T therapy candidate directed at eliminating white blood cells, including residual cancer cells, in HLA-A*02:01-positive...
malignanciestscantherapeutics
https://www.tscan.com/about/advisory-board/
Scientific Advisory Board – TScan Therapeutics
scientific advisory boardtscantherapeutics
https://www.tscan.com/terms-conditions/
Terms and Conditions – TScan Therapeutics
Jul 22, 2019 - TERMS OF USE PLEASE READ THESE TERMS OF USE (“AGREEMENT”) CAREFULLY BEFORE USING THE SERVICES OFFERED BY TSCAN THERAPEUTICS, INC. (“TSCAN”). BY VISITING THE...
termsconditionstscantherapeutics
https://www.tscan.com/
TCR-T Cancer Therapies | TScan Therapeutics
May 12, 2026 - TCR-T Cancer therapies are being developed by TScan Therapeutics, a clinical-stage biotech focused on treating patients.
cancer therapiestcrtscantherapeutics